NCT03851237 2025-12-23
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
Washington University School of Medicine
Phase 1 Completed
Clinical Trials
12 trialsNCT03592888 2025-06-29
DC Vaccine in Pancreatic Cancer
University of Pennsylvania
Phase 1 Completed
NCT05303090 2025-02-27
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic Cancer
Fudan University
Phase 1 Completed
NCT05727319 2025-02-07
AIR-PANC
NHS Greater Glasgow and Clyde
Completed
NCT02767700 2023-10-24
PePaCaKa-01
Karolinska University Hospital
Completed
NCT03257150 2022-08-11
A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer
University Health Network, Toronto
Phase NA Completed
NCT02787187 2021-11-23
Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?
Ruijin Hospital
Phase NA Completed
NCT04310111 2021-08-30
EUS-RFA for Unresectable Pancreatic Cancer
First People's Hospital of Hangzhou
Phase NA Completed
NCT04802993 2021-03-17
Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate
Linkoeping University
Completed
NCT02790944 2020-08-25
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer
Ambry Genetics
Completed
NCT03973736 2019-06-04
RevRadPAC
Azienda USL Reggio Emilia - IRCCS
Completed
NCT02440958 2019-02-18
Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial
Yonsei University
Phase 2 Completed